Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
EDIT
OVID
Add up to 3 more stocks
EDIT
Editas Medicine, Inc.
-1.25%
$2.75-0.04Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$422.79M
52W Range
$1.66 - $4.54
OVID
Ovid Therapeutics Inc.
+2.35%
$2.40+0.06Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$447.00M
52W Range
$1.18 - $3.11
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 4.02 | 2.13 |
| P/S Ratio | 8.99 | 282.38 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 100.0% |
| Operating Margin | -245.2% | -585.2% |
| Net Margin | -157.3% | -2178.9% |
| ROE | -70.2% | -16.4% |
| ROA | -31.1% | -14.9% |
| ROIC | -48.6% | -26.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.19 | 12.39 |
| Quick Ratio | 3.19 | 12.39 |
| Debt/Equity | 0.15 | 0.06 |
| Interest Coverage | -16.10 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.